Position in GILD
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$205,431
-$231,040 QoQ
Shares Held
1,474
-71.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrive Wealth Management, LLC holds $13,579,206 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,510 | $5,716,864 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,054 | $2,319,939 | |
| 3 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 4 | ABBV |
AbbVie Inc.
|
5,708 | $1,436,361 | |
| 5 | AMGN |
Amgen Inc
|
3,218 | $1,165,302 | |
| 6 | PFE |
Pfizer Inc
|
28,655 | $690,012 | |
| 7 | AZN |
Astrazeneca PLC
|
2,264 | $429,299 | |
| 8 | GSK |
GSK plc
|
6,031 | $316,145 |
All Filings in GILD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,431 | 1,474 | Shares | Sole | 2026-04-09 | |
| 2024-09-30 | $436,471 | 5,206 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $479,858 | 6,994 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $430,343 | 5,875 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $629,852 | 7,775 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $538,144 | 7,181 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $541,339 | 7,024 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $586,514 | 7,069 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $531,068 | 6,186 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $375,877 | 6,093 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $296,193 | 4,792 | Shares | Sole | 2022-07-11 | |
| 2021-12-31 | $356,297 | 4,907 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||